Penumbra Inc

NYSE:PEN

251.06

+1.32 (+0.53%)

4:08:15 PM EDT: $250.62 -0.44 (-0.18%)

Market Cap (Intraday)	9.77B
Current PE	231.43
Forward PE	66.59
2yr Forward PE	50.11

See more stats

Estimates Current Quarter

Revenue	$327.77 Million
Adjusted EPS	$0.83

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Penumbra Inc Stock, NYSE:PEN

One Penumbra Place, Alameda, California 94502

United States of America

Phone: +1.510.748.3200

Number of Employees: 4500

http://www.penumbrainc.com

Description

Penumbra, Inc. is a thrombectomy company, which designs, develops, manufactures, and markets innovative medical products. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device system. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004 and is headquartered in Alameda, CA.